Dr. Sambandam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5939 Harry Hines
Ste 700
Dallas, TX 75390Phone+1 214-645-1919Fax+1 214-645-1925
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 2006 - 2008
University of Texas Medical Branch School of MedicineClass of 2003
Certifications & Licensure
TX State Medical License 2008 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- Nephrotic Syndrome Study Network Start of enrollment: 2010 Apr 01
- Diuretic Tuner Clinical Decision Support Start of enrollment: 2023 Nov 20
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 17 citationsPrognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased ris...Cristina Arriens, Sixia Chen, David R. Karp, Ramesh Saxena, Kamalanathan K. Sambandam
Clinical Immunology. 2017-12-01 - 39 citationsPerturbations in serum chloride homeostasis in heart failure with preserved ejection fraction: insights from TOPCAT.Justin L. Grodin, Jeffrey M. Testani, Ambarish Pandey, Kamalanathan K. Sambandam, Mark H. Drazner
European Journal of Heart Failure. 2018-10-01 - 24 citationsCadherin-11, Sparc-related modular calcium binding protein-2, and Pigment epithelium-derived factor are promising non-invasive biomarkers of kidney fibrosis.Insa M. Schmidt, Mia R. Colona, Bryan Kestenbaum, Leonidas G. Alexopoulos, Ragnar Palsson
Kidney International. 2021-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
